Viewing Study NCT03933761


Ignite Creation Date: 2025-12-24 @ 12:15 PM
Ignite Modification Date: 2025-12-30 @ 8:39 AM
Study NCT ID: NCT03933761
Status: WITHDRAWN
Last Update Posted: 2021-08-10
First Post: 2019-04-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pamiparib in Fusion Positive, Reversion Negative High Grade Serous Ovarian Cancer or Carcinosarcoma With BRCA1/2 Gene Mutations If Progression on Substrate Poly ADP Ribose Polymerase Inhibitbor (PARPI) or Chemotherapy
Sponsor: Australia New Zealand Gynaecological Oncology Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module